22nd Century Other Operating Income or Expenses 2011-2025 | XXII
22nd Century other operating income or expenses from 2011 to 2025. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
22nd Century Annual Other Operating Income or Expenses
(Millions of US $) |
| 2024 |
$0 |
| 2023 |
$-3 |
| 2022 |
$0 |
| 2021 |
$0 |
| 2020 |
$0 |
| 2019 |
$-1 |
| 2018 |
$0 |
| 2017 |
$0 |
| 2016 |
$0 |
| 2015 |
$0 |
| 2014 |
$-1 |
| 2013 |
$0 |
| 2012 |
$0 |
| 2011 |
$0 |
| 2010 |
$0 |
22nd Century Quarterly Other Operating Income or Expenses
(Millions of US $) |
| 2025-03-31 |
|
| 2024-12-31 |
$0 |
| 2024-09-30 |
$0 |
| 2024-06-30 |
$0 |
| 2024-03-31 |
$0 |
| 2023-12-31 |
$-2 |
| 2023-09-30 |
$-1 |
| 2023-06-30 |
|
| 2023-03-31 |
$0 |
| 2022-12-31 |
$1 |
| 2022-09-30 |
$0 |
| 2022-06-30 |
$-1 |
| 2022-03-31 |
$0 |
| 2021-12-31 |
|
| 2021-09-30 |
|
| 2021-06-30 |
|
| 2021-03-31 |
|
| 2020-12-31 |
$0 |
| 2020-09-30 |
|
| 2020-06-30 |
$0 |
| 2020-03-31 |
|
| 2019-12-31 |
|
| 2019-09-30 |
$-1 |
| 2019-06-30 |
|
| 2019-03-31 |
|
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2018-03-31 |
|
| 2017-12-31 |
|
| 2017-09-30 |
|
| 2017-06-30 |
|
| 2017-03-31 |
|
| 2016-12-31 |
|
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
|
| 2015-12-31 |
|
| 2015-09-30 |
|
| 2015-06-30 |
|
| 2015-03-31 |
|
| 2014-12-31 |
$0 |
| 2014-09-30 |
$0 |
| 2014-06-30 |
$0 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
|
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
|
| 2011-03-31 |
|
| 2010-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.003B |
$0.024B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
